Menu
Back to Journals » Lung Cancer: Targets and Therapy » Volume 10
Original Research
Time To Response In Patients With Advanced Anaplastic Lymphoma Kinase (ALK)-Positive Non-Small-Cell Lung Cancer (NSCLC) Receiving Alectinib In The Phase II NP28673 And NP28761 Studies
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 7,513 | Dovepress* | 6,460+ | 952 | 7,412 | |
| PubMed Central* | 1,053 | 205 | 1,258 | ||
| Totals | 7,513 | 1,157 | 8,670 | ||
| *Since 13 November 2019 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 2 | 0 | 0 | 1 | 0 | 1 |
View citations on PubMed Central and Google Scholar